Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharma CEOs Tackle A Tough Question: “Why Don’t People Like You?”

Executive Summary

Pfizer CEO Ian Read, Regeneron CEO Leonard Schleifer, Gilead CEO John Milligan and Lilly’s incoming CEO David Ricks discussed pharma’s reputation problem during the Forbes Healthcare Summit.

Advertisement

Related Content

Sanofi, Regeneron Setting 'New Paradigm' With Dupixent Pricing In US?
Pfizer On Obamacare Rewind: No Short-Term Impact On Industry
Pfizer On Obamacare Rewind: No Short-Term Impact On Industry
Lilly’s Insulin Discounts Target High-Deductible Insurance Gaps
Mylan CEO Takes Center Stage To Address EpiPen Pricing Scandal
Payers Want Access To US FDA's Pre-Submission Meetings
Bridging The Drug Price Divide: Ideas And Approaches Debated At PSA
The Price War On Drugs: HCV Competition Finally Sparks Discounting

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC097810

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel